World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
81
Citations
38464
World Ranking
1078
National Ranking
488

Overview

Emilio A. Emini is affiliated with Pfizer in the United States. Their research primarily focuses on medicine, with specific interests in infectious diseases, genetics, and hepatology. The scientist's work spans multiple topics including HIV/AIDS drug development and treatment, chronic lymphocytic leukemia research, and hepatitis C virus research.

Among the recent publications, there is a paper titled "Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy," published in 2020 in UNC Libraries. This publication recorded citations in the academic community reflecting engagement with the work.

Frequent collaborators include John W. Mellors, Leslie Jonas, Fred Valentine, Roy M. Gulick, and Diane V. Havlir. These coauthors have appeared alongside Emilio A. Emini in published research, contributing to studies in their shared fields of interest.

Publication venues for Emilio A. Emini's research are noted to include UNC Libraries, showcasing contributions to that platform.

Main topics of their research work are as follows:

  • HIV/AIDS drug development and treatment
  • Chronic Lymphocytic Leukemia Research
  • Hepatitis C virus research

Coauthors frequently involved in Emilio A. Emini's works include:

  • John W. Mellors
  • Leslie Jonas
  • Fred Valentine
  • Roy M. Gulick
  • Diane V. Havlir

Main fields of study pursued are:

  • Medicine

Subfields of study where Emilio A. Emini has contributed include:

  • Infectious Diseases
  • Genetics
  • Hepatology

This profile summarizes the academic research footprint of Emilio A. Emini, reflecting their involvement in medical sciences and infectious disease research through collaborative publications and topical expertise.

Best Publications

  • Viral dynamics in human immunodeficiency virus type 1 infection

    Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson

  • Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

    R M Gulick;J W Mellors;D Havlir;J J Eron

  • Active human immunodeficiency virus protease is required for viral infectivity.

    Nancy E. Kohl;Emilio A. Emini;William A. Schleif;Lenora J. Davis

  • Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

    E A Emini;J V Hughes;D S Perlow;J Boger

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • Primary structure, gene organization and polypeptide expression of poliovirus RNA

    Naomi Kitamura;Bert L. Semler;Paul G. Rothberg;Glenn R. Larsen

  • In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

    Unknown

  • L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase.

    S D Young;S F Britcher;L O Tran;L S Payne

  • Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

    E. A. Emini;W. A. Schleif;J. H. Nunberg;J. H. Nunberg;A. J. Conley

  • Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene

    Danilo R. Casimiro;Ling Chen;Tong-Ming Fu;Robert K. Evans

  • L-735,524 : the design of a potent and orally bioavailable HIV protease inhibitor

    B D Dorsey;R B Levin;S L McDaniel;J P Vacca

  • Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.

    J H Nunberg;W A Schleif;E J Boots;J A O'Brien

  • Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

    Jiang Fan;Xiaoping Liang;Melanie S Horton;Helen C Perry

  • A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

    Daria J. Hazuda;Neville J. Anthony;Robert P. Gomez;Samson M. Jolly

  • Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.

    John W Shiver;Emilio A Emini

  • Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody.

    M K Gorny;A J Conley;S Karwowska;A Buchbinder

  • Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

    Daria J. Hazuda;Steven D. Young;James P. Guare;Neville J. Anthony

  • Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Andrés de Roux;B. Schmöele-Thoma;G. R. Siber;J. G. Hackell

  • Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

    Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang

  • 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

    T M Williams;T M Ciccarone;S C MacTough;C S Rooney

  • Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure

    Joseph K. Wong;Huldrych F. Günthard;Diane V. Havlir;Zhi Qiang Zhang

Frequent Co-Authors

John W. Shiver
John W. Shiver United States Military Academy
Danilo R. Casimiro
Danilo R. Casimiro United States Military Academy
William C. Gruber
William C. Gruber Pfizer (United States)
Daniel A. Scott
Daniel A. Scott Pfizer (United States)
Eckard Wimmer
Eckard Wimmer Stony Brook University
Tong-Ming Fu
Tong-Ming Fu The University of Texas Health Science Center
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Joseph P. Vacca
Joseph P. Vacca MSD (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various career pathways beyond traditional lab roles. Many professionals explore related fields that combine biology and healthcare, offering diverse options for growth and specialization. For those with unique challenges, there are accessible educational opportunities such as online degrees for felons, which provide a vital second chance for pursuing science-related careers.

Healthcare roles like a Functional Medicine Nurse Practitioner offer promising career prospects. With a focus on holistic and integrative approaches, the functional medicine nurse practitioner salary reflects the growing demand for professionals skilled in this area, making it a lucrative pathway for microbiology graduates interested in patient care.

Another viable option involves health administration, where skills in coding and data management are critical. Becoming a Certified Professional Coder (CPC) links medical knowledge with precise documentation and billing processes. Understanding the cpc salary offers insights into the financial benefits of this career.

Similarly, careers in health information management allow microbiology graduates to manage healthcare data systems effectively. Entry-level roles show promising growth, highlighted by the health information management salary entry-level, making it an attractive option for those interested in the intersection of healthcare and technology.

Best Scientists Citing Emilio A. Emini

Trending Scientists

Recently Published Articles